Cargando…
2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype
Due to limited availability of pharmacological therapies, triple-negative breast cancer (TNBC) is the subtype with worst outcome. We hypothesised that 2-Deoxy-D-Glucose (2-DG), a glucose analogue, may hold potential as a therapy for particularly aggressive TNBC. We investigated 2-DG’s effects on TNB...
Autores principales: | O’Neill, Sadhbh, Porter, Richard K., McNamee, Niamh, Martinez, Vanesa G., O’Driscoll, Lorraine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405919/ https://www.ncbi.nlm.nih.gov/pubmed/30846710 http://dx.doi.org/10.1038/s41598-019-39789-9 |
Ejemplares similares
-
An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer
por: McNamee, Niamh, et al.
Publicado: (2023) -
Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles
por: Martinez, Vanesa G., et al.
Publicado: (2017) -
Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
por: Mukhopadhya, Anindya, et al.
Publicado: (2023) -
A method of separating extracellular vesicles from blood shows potential clinical translation, and reveals extracellular vesicle cargo gremlin-1 as a diagnostic biomarker
por: McNamee, Niamh, et al.
Publicado: (2021) -
Proteomics profiling identifies extracellular vesicles’ cargo associated with tumour cell induced platelet aggregation
por: McNamee, Niamh, et al.
Publicado: (2022)